We are currently investigating innovative approaches to speed up and further improve the image quality of our DWIBS sequences. These approaches are utilizing new technologies which have only recently become available on only the most advanced MRI scanners.
We are also investigating new techniques for investigating the prostate gland. As the prostate undergoes some localized changes when tumors form, these changes may alter the gland in a way that may be seen with some novel MRI techniques.
Finally, we are researching and preparing a paper on the breakdown products of blood. As we already know, MRI is fantastic at imaging stroke patients. We are looking to further this knowledge, which may assist in stroke rehabilitation in the future.
Jan. 29/2013 – Lung and Colon Cancer Research Trial
As part of AIM Medical Imaging’s commitment to advancing state-of-the-art diagnostic imaging in Canada, we are pleased to announce a new phase of research into early cancer diagnosis.
In United States and abroad, patients who are suspected of having cancer are provided with a staging functional imaging test (usually PETCT), which is used as a baseline to monitor the response to cancer treatment. Unfortunately, this baseline study is not routinely performed in BC, and thus assessing response to treatment can be delayed, or is unknown.
At AIM, we are seeking patients suspected of having lung, and colon cancer to participate in our research study. If eligible, these patients will be offered a state-of-the-art whole body MRI, and staging PETCT.
We are currently working with a pharmaceutical company investigating the utilization of MRI for Crohn’s Disease research and follow up. At this preliminary stage our imaging techniques appear to be extremely robust and, unlike CT, avoid the use of ionizing radiation.
We are also investigating the positive and negative aspects of performing MRI with a continuous moving table. There are very few machines with this capability worldwide. If we can demonstrate MRI has superior lesion detection to to CT with a similar scan time with this technique, then we may be able to shift the routine imaging away from CT for the sake of patient care.
Diffusion-weighted magnetic resonance imaging (DWI) provides functional information and can be used for the detection and characterization of pathologic processes, including malignant tumors. Cancer is the second leading cause of death in developed countries, is among the three leading causes of death for adults in developing countries, and is responsible for many deaths worldwide.